Home / Inspections / 1305080

FDA Inspection 1305080 — Greater Baltimore Medical Center

Greater Baltimore Medical Center — FEI 1173170

The FDA completed an inspection of Greater Baltimore Medical Center on February 5, 2026 in Towson, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 5, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Towson, MD (United States)

Facility

Other inspections at this facility

  • 1221203 (VAI Thu Oct 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1121801 (NAI Fri Nov 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1038518 (NAI Fri Dec 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 982274 (NAI Thu Jul 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 862071 (NAI Wed Jan 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources